-transparent.png){kind=logo}
There is increasing evidence that aluminium accumulation in patients with impaired renal function has pathological consequences. The serum aluminium content of 45 patients with chronic renal failure was found to be significantly elevated when compared with normal subjects. A further rise in serum aluminium concentration was seen in patients with chronic renal failure when they were taking aluminium-containing phosphate binding agents. Patients with stable but moderately impaired renal function who are taking aluminium-containing phosphate binders for several years may be at risk from aluminium accumulation and the development of osteomalacia and encephalopathy as seen in patients on intermittent haemodialysis.
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
January 1989,
Nephron,
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
November 1991,
British journal of industrial medicine,
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
June 1980,
Nihon Jinzo Gakkai shi,
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
February 1986,
British medical journal (Clinical research ed.),
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
November 1971,
British medical journal,
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
October 2000,
Nephron,
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
January 2002,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
November 1983,
Journal of clinical pathology,
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
December 1986,
Lancet (London, England),
S N Marsden, and
I S Parkinson, and
M K Ward, and
H A Ellis, and
D N Kerr
October 1971,
British medical journal,
